Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/eurheartj/ehae179 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but serious disease caused by persistent thromboembolic obstruction or narrowing of the pulmonary arteries. Its prevalence varies, and many cases remain undiagnosed, contributing to a substantial clinical burden. This study aimed to summarize all CTEPH cases diagnosed in Latvia in 2024, calculate the annual incidence, and present additional epidemiological data from Latvian pulmonary hypertension (PH) registry.
View Article and Find Full Text PDFWhen chest pain is not what it seems: time for right diagnosis and right treatment-a case report.
Eur Heart J Case Rep
September 2025
Department of Cardiovascular Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. Gemelli 1, Rome 00168, Italy.
Background: Chest pain is a common reason for emergency department (ED) visits, yet not all cases are attributable to coronary artery disease (CAD). The 2024 European Society of Cardiology (ESC) guidelines emphasize the importance of invasive coronary function testing in patients with angina and non-obstructive coronary arteries. Understanding alternative causes of chest pain is crucial for appropriate diagnosis and management.
View Article and Find Full Text PDFPerformance of Different Versions of Duke Criteria in Diagnosing Infective Endocarditis in Patients With Intracardiac Prosthetic Materials.
Open Forum Infect Dis
September 2025
Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Background: Diagnosing infective endocarditis (IE) is a significant challenge. This study aimed to compare the diagnostic performance of the 2015 and 2023 European Society of Cardiology (ESC) and the 2023 International Society for Cardiovascular Infectious Diseases (ISCVID) Duke clinical criteria in a cohort of patients with suspected IE and intracardiac prosthetic material.
Methods: This retrospective study was conducted at 2 Swiss University Hospitals (2014-2024).
Cardiovascular Risk Across Blood Pressure Categories Defined by the 2024 ESC and 2023 ESH Hypertension Guidelines: Insights from a Korean Nationwide Cohort Study.
Eur J Prev Cardiol
September 2025
Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Korea.
Background And Aims: The most recent guidelines from the European Society of Cardiology (ESC) categorize blood pressure (BP) into three groups: (1) non-elevated BP, (2) elevated BP and (3) hypertension. This study aimed to determine whether the 2024 guidelines from the ESC for elevated BP and hypertension accurately identify populations at increased risk of future cardiovascular diseases.
Methods: In a population-based cohort derived from the Korean National Health Insurance Service database, we included individuals aged ≥40 years who underwent national health examinations in 2009.
Invasive treatment strategies in the ESC guidelines developed in collaboration with EACTS for the management of chronic coronary syndrome: implications for contemporary clinical practice.
Curr Opin Cardiol
September 2025
Department of Cardiology and Cardiovascular Research, Dedinje Cardiovascular Institute.
Purpose Of Review: To critically appraise the 2024 ESC Guidelines for chronic coronary syndrome (CCS), developed in collaboration with EACTS, emphasizing invasive-treatment recommendations, their underlying rationale and key areas requiring further clarification for clinical implementation.
Recent Findings: The document formally incorporates indications for myocardial revascularization and the criteria for choosing between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) into the single CCS guideline framework. It calls for Heart-Team decisions whenever CABG and PCI are equally recommended and introduces modality-specific criteria based on anatomical complexity, SYNTAX score, and clinically relevant comorbidities.